Onsdag 17 December | 03:55:53 Europe / Stockholm

Kalender

Est. tid*
2026-08-13 07:00 Kvartalsrapport 2026-Q2
2026-05-13 N/A Årsstämma
2026-02-26 N/A Bokslutskommuniké 2025
2025-07-31 - Kvartalsrapport 2025-Q2
2025-05-16 - X-dag ordinarie utdelning CRBN 0.64 EUR
2025-05-14 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-08-08 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning CRBN 0.61 EUR
2024-05-15 - Årsstämma
2024-05-02 - X-dag bonusutdelning CRBN 0.1
2024-03-01 - Bokslutskommuniké 2023
2023-08-10 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning CRBN 0.56 EUR
2023-05-17 - Årsstämma
2023-03-03 - Bokslutskommuniké 2022
2022-08-10 - Kvartalsrapport 2022-Q2
2022-07-05 - Extra Bolagsstämma
2022-05-20 - X-dag ordinarie utdelning CRBN 0.56 EUR
2022-05-18 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-10-27 - Kvartalsrapport 2021-Q3
2021-07-20 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning CRBN 0.56 EUR
2021-05-19 - Årsstämma
2021-04-30 - Kvartalsrapport 2021-Q1
2021-03-05 - Bokslutskommuniké 2020
2020-10-12 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning CRBN 0.56 EUR
2020-06-29 - Årsstämma
2020-04-30 - Kvartalsrapport 2020-Q1
2020-01-13 - Bokslutskommuniké 2019
2019-11-01 - Kvartalsrapport 2019-Q3
2019-08-07 - Kvartalsrapport 2019-Q2
2019-08-05 - Extra Bolagsstämma
2019-04-26 - Kvartalsrapport 2019-Q1

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-11-07 07:00:00

Corbion announces the signing of a Note Purchase Agreement for a total debt issuance of USD 100 million in the US Private Placement (USPP) market, with a fixed interest rate of 5.11% and a maturity of 7 years.

The final closing, issuance of notes, and funding are scheduled for December 18, 2025; subject to standard closing conditions. The proceeds from this USPP will be used to repay maturing debt due in December 2025. This program will further align the well-spread maturity profile of Corbion’s outstanding debt.


Disclaimer
Corbion offered the notes to certain institutional investors in an exempt private placement made pursuant to an exemption from the registration requirements under the U.S. Securities Act of 1933, as amended (the “Act”). The notes have not been and will not be registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Act.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any security, in the United States or elsewhere, and in any event shall not constitute an offer, solicitation, or sale of any securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful.